Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Operating activities:
Net loss	$ (314,975)	$ (897,346)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	653,625	734,763
Stock-based compensation	25,332	52,083
Non-cash life insurance policy accretion	(90,406)	(87,732)
(Gain) loss on sale of property, plant and equipment	(8,906)
Deferred income taxes	(6,000)	27,000
Foreign currency transaction (gain) loss	(29,299)	(191,091)
(Increase) decrease in accounts receivable and accounts due from employees and distributors	98,634	81,571
(Increase) decrease in inventories	(313,382)	868,287
(Increase) decrease in refundable income taxes	49,500	(2,153)
(Increase) decrease in prepaid expenses and other current assets	(21,418)	(71,431)
(Increase) decrease in other assets	(30,196)	(4,180)
Increase (decrease) in income taxes payable	26,950
Increase (decrease) in accounts payable & accrued expenses and other noncurrent liabilities	(632,607)	253,012
Net cash provided by (used in) operating activities	(593,148)	762,783
Investing activities:
Purchase of property, plant and equipment	(430,083)	(18,686)
Proceeds from the sale of property, plant and equipment	13,001	912
Payments received on distributor note receivable	81,254	76,534
Net cash provided by (used in) investing activities	(335,828)	58,760
Financing activities:
Principal payments on long-term borrowings	(282,496)	(904,461)
Net cash used in financing activities	(282,496)	(904,461)
Effect of exchange rate changes on cash and cash equivalents	70,066	(9,337)
Increase (decrease) in cash and cash equivalents	(1,141,406)	(92,255)
Cash and cash equivalents at beginning of period	3,606,817	3,262,263
Cash and cash equivalents at end of period	$ 2,465,411	$ 3,170,008